We provide evidence for a role of the KRAS/BCL-XL interaction in the transition towards a CIC state together with the conceptual framework and tools to unravel its molecular basis, its regulation and biological outputs in breast cancer cell populations and CIC subsets. Here, BCL2L1 is linked to breast cancer.